TCT
ARIA

TIAA CREF Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

TIAA CREF Trust’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,000
Closed -$373K – 376
2016
Q4 		$373K Hold
30,000
– – ﹤0.01% 329
2016
Q3 		$411K Hold
30,000
– – ﹤0.01% 336
2016
Q2 		$222K Buy
+30,000
New +$225K ﹤0.01% 343
2013
Q4 		– Sell
-20,100
Closed -$370K – 304
2013
Q3 		$370K Hold
20,100
– – 0.01% 247
2013
Q2 		$352K Buy
+20,100
New +$356K 0.01% 243

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

TIAA CREF Trust's ARIA Position: Q1 2017 in Review

TIAA CREF Trust sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 30,000 shares — an estimated $373K sold.

TIAA CREF Trust first reported a position in ARIA in Q2 2013 and held it in 5 quarters. The position peaked at $411K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • TIAA CREF Trust reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • TIAA CREF Trust sold 30,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $373K.
  • TIAA CREF Trust first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • TIAA CREF Trust's Ariad Pharmaceuticals Inc position peaked at $411K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.